2018 American Society of Clinical Oncology (ASCO)

Meet us at booth 4113 and learn about our new HTG EdgeSeq Precision Immuno-Oncology Panel designed to simplify complex tumor biology and accelerate the development of clinical biomarkers.  The new panel features applications such as the immunophenotyping of tumor infiltrating lymphocytes (TILs); monitoring of immunotherapy response biomarkers; and the elucidation of immune-escape mechanisms known to drive disease progression.

Using only a single 5 µm formalin-fixed, paraffin-embedded (FFPE) tissue section, the panel is able to profile over 1,400 genes, without the RNA extraction and complex workflow associated with standard RNA-seq methods. Together with the HTG EdgeSeq system, users will have the ability to profile using a wide variety of sample types allowing them to accelerate discovery, support translational applications, and determine potential biomarkers for development of companion diagnostics.

McCormick Place | Chicago, IL | June 1 - June 5 | Booth #4113 | Meeting Room MR1 on Exhibit Hall Floor